Rankin A C, Rae A P, Oldroyd K G, Cobbe S M
University Department of Medical Cardiology, Royal Infirmary, Glasgow.
Q J Med. 1990 Feb;74(274):203-8.
A comparison of verapamil with adenosine for the immediate treatment of supraventricular tachycardia was made from a retrospective review of 164 spontaneous episodes of paroxysmal tachycardia in 43 patients. Verapamil administered to 33 patients restored sinus rhythm in 91 of 112 episodes (81 per cent). Hypotension occurred in 9 per cent of episodes. Adenosine terminated 94 per cent of episodes of supraventricular tachycardia in 25 patients. The arrhythmia recurred shortly after adenosine restored sinus rhythm in 20 episodes. Transient side effects were common. Fifteen patients were treated with both agents. Adenosine was successful in all, but verapamil failed to restore sinus rhythm at least once in seven of the 15 patients. Early recurrence of tachycardia occurred in five of these after adenosine, but in only one after verapamil. Verapamil and adenosine are both effective in the treatment of supraventricular tachycardia; adenosine has the higher success rate and is safer, but transient symptoms are common and arrhythmias may recur.
通过对43例患者164次阵发性心动过速自发发作进行回顾性分析,比较了维拉帕米和腺苷用于室上性心动过速即刻治疗的效果。33例患者使用维拉帕米,在112次发作中有91次(81%)恢复窦性心律。9%的发作出现低血压。25例患者使用腺苷,94%的室上性心动过速发作得以终止。20次发作中,腺苷恢复窦性心律后心律失常很快复发。短暂副作用很常见。15例患者接受了两种药物治疗。腺苷在所有患者中均有效,但15例患者中有7例至少有一次维拉帕米未能恢复窦性心律。其中5例在使用腺苷后心动过速早期复发,但使用维拉帕米后只有1例复发。维拉帕米和腺苷在治疗室上性心动过速方面均有效;腺苷成功率更高且更安全,但短暂症状常见且心律失常可能复发。